Trial Profile
Clinical study of COVID-19 LinearDNA™ Vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2020
Price :
$35
*
At a glance
- Drugs Linear DNA based coronavirus vaccines-LineaRx/Takis (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 21 Apr 2020 New trial record
- 15 Apr 2020 According to an Applied DNA Sciences media release, this trial is scheduled to begin this fall.